| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |